社会福祉法人はばたき福祉事業団 オフィシャルサイト

National Center for Global Health and Medicine (NCGM) has launched Dendritic Cell (DC) vaccine or so-called Dendritic Cell therapy for cancer from April, 2012. March 22, 2012, NCGM (TOKYO) announced the news release. They are planning to conduct antigen-loaded DC vaccinations representing a safe and promising form of immunotherapy for patients from April, 2012. Based on provision of clinical research, they are expected to carry out more than 10 cases by the month. Dendritic Cell vaccine is to extract dendritic cell derived from human and compulsory loaded with malignant cells, then cultured and followed by injecting subcutaneously. DCs taken up inside the body, present malignant cells information to lymphocytes, enabling themselves to intensively attack against cancer cells. According to NCGM, Food and Drug Administration (FDA) agency of the U.S. federal government already approved DC vaccine for prostate cancer and brain tumor two years ago. NCGM researchers are planning to culture and developed DC vaccine in their new culture facility that start working in April with the use of antigen peptides such as WT1 and MUC1 expressing in multi malignant cells, serving them to patients. Their ultimate goal is to obtain an authorization from government as advanced medicine in the future. The methods of DCs Vaccine will be provided by tella, Inc (TOKYO). Reference by Nikkan Yakugyou issued on March 23, 2012 According to Tella, Inc press release, they have already provided 18 hospitals until October, 2011. So NCGM is 19th and Keio University will follow DC vaccine therapy. This research is energetically being conducted by Nagasaki University in response to HIV/HCV-positive hemophiliacs developing liver cancer, who desperately desire for living under utterly hopeless condition. This research will be conducted in institution organized by AIDS Clinic Center(ACC) at NCGM, which focuses in rescue work for HIV-positive hemophiliacs in Japan as a permanent compensation. Many our peers were co-infected with HIV and HCV, leading to cirrhosis of the liver and liver cancer and consequently death. Even now, the reality shows that there are many patients developing into liver cancer without being having immediate, effective and actual treatment much less liver transplantation. Since Japanese government is responsible for spreading HIV-tainted blood scandal among Japanese hemophiliacs, they must promote rescue work with their efforts as well as pioneer these advanced medical cares, regardless of when and how the phase is.